Observational, prospective, single-center follow-up study carried out with patients from the area of the Virgen de Macarena University Hospital, diagnosed with chronic kidney disease, who started treatment with ustekinumab.
Prospective follow-up observational study carried out with patients from the Virgen de Macarena University Hospital, under treatment with ustekinumab in the induction and maintenance phase in order to determine the cut-off points of the ustekinumab levels between which a clinical remission is expected in patients with inflammatory bowel disease.
Study Type
OBSERVATIONAL
Enrollment
95
Hospital Universitario Virgen de Macarena
Seville, Spain
RECRUITINGDetermine breakpoints.
To determine the breakpoints for ustekinumab levels between which clinical remission is expected in patients with inflammatory bowel disease.
Time frame: Up to 44 weeks.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.